BIIB

Biogen (BIIB) Stock Analysis

Research Biogen (BIIB) with company financials, earnings context, valuation indicators, risk analysis and related market news.

Research record updated: . Individual measures may refer to different reporting periods.

Ticker
BIIB
Company
Biogen
Sector
Healthcare
Industry
Drug Manufacturers - General
Market cap
$32.91B
Financial data source
FMP financial statements + FMP cash flow statements + FMP balance sheet + income statements
Annual revenue (reporting year not supplied)
$9.81B
Annual net income (reporting year not supplied)
$1.29B
Annual free cash flow (reporting year not supplied)
$2.05B
Trailing revenue
$9.95B
Trailing net income
$835.09M
Total assets
$29.44B
Total liabilities
$11.18B

Biogen (BIIB) Stock Analysis research

Review the available company profile, financial history, valuation context and investor signals for Biogen. Compare the reported operating results with the valuation and risk measures below.

The figures are cached research data and can change after new filings, earnings reports or market updates. Verify material facts with primary company disclosures before making an investment decision.